4-butyrolactone has been researched along with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Akunne, HC; Cooke, LW; Davis, MD; DeMattos, SB; Georgic, LM; MacKenzie, RG; Rugsley, TA; Shih, YH; van Leeuwen, DH; Whetzel, SZ | 1 |
1 other study(ies) available for 4-butyrolactone and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine
Article | Year |
---|---|
CI-1007, a dopamine partial agonist and potential antipsychotic agent. I. Neurochemical effects.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 4-Butyrolactone; Acetylcholine; Adenylyl Cyclases; Animals; Antipsychotic Agents; Autoreceptors; CHO Cells; Cricetinae; Dihydroxyphenylalanine; Dopamine; Dopamine Agonists; Guinea Pigs; Male; Rats; Rats, Sprague-Dawley; Receptors, Dopamine; Serotonin | 1995 |